new version V2017

Lixisenatide antidiabetic drugs

AQVE-10010 - Lixisenatide - AVE-0010 - AVE0010 - AVE 0010 - ZP10A peptide      

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

diabetes type 2

ELIXAlixisenatideplacebo Exploratory NegativeNCT01147250
GETGOAL-Llixisenatideglargine once daily - NCT00715624
GetGoal-X ongoing lixisenatideexenatide Exploratory - NCT00707031
ELIXA (EFC11319) ongoing lixisenatideplacebo - NCT01147250
GetGoal Duo1 ongoing lixisenatideplacebo (add on basal insulin) - NCT00975286
GetGoal-M-As ongoing lixisenatideplacebo (add on MET+/-SU) - NCT01169779
EFC10780, 2010 ongoing lixisenatidesitagliptin (add on MET) - NCT00976937